Investor Stock List
#10,322 by institutional money · Stock

enGene Therapeutics Inc. (ENGNW)

Institutional ownership from Q3 2026 Form 13F filings

$0.16
−10.34% today
Market closed. Prices as of Nov 20, 7:11 AM ET
13F holders
11 (+1)
Held by 13F filers, live
$398K
Shares held
2,469,302
Share of stock outstanding
n/a
Net buying in Q3 2026
+$1K
New positions / sold out
2 / 1

Largest holders

11 investors
InvestorSharesValue, live% of their portfoliovs Q2 2026
BVF Inc/il945,402$152K<0.1%Unchanged
Blue Owl Capital Holdings LP511,177$82K<0.1%Unchanged
Caption Management, LLC333,675$54K<0.1%Unchanged
LMR Partners LLP309,763$50K<0.1%Unchanged
Aristeia Capital, L.l.c.197,678$32K<0.1%Unchanged
D. E. Shaw & Co., Inc.104,622$17K<0.1%Unchanged
Toronto Dominion Bank31,645$5K<0.1%Added +0%
CSS LLC/il16,895$3K<0.1%Unchanged
Susquehanna International Group, LLP16,801$3K<0.1%New
Wolverine Asset Management LLC1,344$217<0.1%New
Clear Street Group Inc.300$48<0.1%Added +50%